Urine test for monitoring prostate or bladder cancer
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial is testing if a simple urine test can help track prostate or bladder cancer over time without needing invasive procedures. It includes five specific patient groups with different stages of these cancers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have high-risk localized prostate cancer and are getting high-dose radiation therapy.
- You have metastatic hormone-sensitive prostate cancer and are starting docetaxel chemotherapy.
- You have metastatic castration-resistant prostate cancer in second-line treatment and are getting LuPSMA therapy.
- You have localized bladder cancer and are getting chemotherapy before surgery.
- You have metastatic bladder cancer and are starting enfortumab vedotin with pembrolizumab.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for urine markers (proteins and metabolites) that may help predict how prostate cancer patients respond to treatment and what their outcomes are. You may be asked to give a urine sample and allow use of your medical and treatment details for analysis (results are not shared with you).
This trial tests a new blood test that looks for signs bladder cancer may be coming back in people with a recent history of bladder cancer. It may help by making surveillance easier, but you must still follow a scheduled bladder-check plan.
This study tests whether a protein called CREPT found in urine can help doctors diagnose bladder cancer or monitor patients who already have it. Researchers will compare urine samples from people with bladder cancer, people with other bladder conditions, and healthy volunteers.
This study is testing a new, non-invasive urine test that looks for specific DNA changes (methylation patterns) to find bladder cancer early. If you have bladder cancer or are a healthy person willing to help, you may be able to join.
This study looks for new urine markers (signals) that could help screen for prostate cancer. If you have a higher PSA blood test and are scheduled for a prostate biopsy, your urine sample may be studied to see if it can improve screening.
This study tests a new non-invasive urine test (Xpert Bladder Monitor) to see if it can catch bladder cancer coming back early, reducing the need for frequent cystoscopy. It is for people with high-grade or high-risk non-muscle invasive bladder cancer who have had or are still having BCG treatment.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.